Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Novel Immuno-oncology Strategies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7
Intratumoral toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab can reverse resistance to PD-1 inhibition in a phase Ib trial in subjects with advanced melanoma
Mohammed Milhem
University of Iowa, Iowa City, IA, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
Discussant
Jedd Wolchok
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
A Cancer Research UK phase I trial of anti-GD2 chimeric antigen receptor (CAR) transduced T-cells (1RG-CART) in patients with relapsed or refractory neuroblastoma
Karin Straathof
UCL Great Ormond Street Institute of Child Health, London, United Kingdom
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
First-in-human phase I combination of the IL-15 receptor super agonist complex ALT-803 with a therapeutic (anti-CD20) monoclonal antibody (mAb) for patients with relapsed or refractory indolent non-Hodgkin lymphoma (iNHL)
Todd A Fehniger
Washington University School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
Discussant
Thomas A. Waldmann
National Cancer Inst., Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
Safety and efficacy of high purity and activity NK cells therapy in combination with IgG1 antibody in patients with gastric or colorectal cancer: A phase I clinical trial
Naoyuki Sakamoto
Kyoto Prefectural University of Medicine, Kyoto, Japan
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
Discussant
William Carson
Ohio State Univ., Columbus, OH, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:35 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 7 of 7